MoneyWorks4Me

Gland Pharma - Quaterly Results

05 Aug 2025 Evaluate
A minor change in the total revenue was seen in the June 2025 quarter. The total revenue for the quarter stood at Rs. 10388.35 millions against Rs. 10120.24 millions during year ago period.The Company has registered profit of Rs. 2692.58  millions for the quarter ended June 2025, a growth of 20.79%  over Rs. 2229.21 millions millions achieved in the corresponding quarter of last year.Operating Profit saw a handsome growth to 4135.86 millions from 3420.43 millions in the quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 10388.35 10120.24 2.65 10388.35 10120.24 2.65 41161.49 41674.28 -1.23
Other Income 547.41 484.90 12.89 547.41 484.90 12.89 2150.75 1666.66 29.05
PBIDT 4135.86 3420.43 20.92 4135.86 3420.43 20.92 16576.93 15754.47 5.22
Interest 74.35 9.11 716.14 74.35 9.11 716.14 228.37 78.43 191.18
PBDT 4061.51 3411.32 19.06 4061.51 3411.32 19.06 16348.56 15676.04 4.29
Depreciation 437.68 408.17 7.23 437.68 408.17 7.23 1692.71 1621.07 4.42
PBT 3623.83 3003.15 20.67 3623.83 3003.15 20.67 14655.85 14054.97 4.28
TAX 931.25 773.94 20.33 931.25 773.94 20.33 3758.32 3621.72 3.77
Deferred Tax -1.46 11.82 -112.35 -1.46 11.82 -112.35 91.24 246.84 -63.04
PAT 2692.58 2229.21 20.79 2692.58 2229.21 20.79 10897.53 10433.25 4.45
Equity 164.76 164.75 0.01 164.76 164.75 0.01 164.76 164.71 0.03
PBIDTM(%) 39.81 33.80 17.80 39.81 33.80 17.80 40.27 37.80 6.53
Peers
Company Name CMP
Sun Pharma. Inds. 1868.00
Dr. Reddys Labs. 1202.00
Cipla 1385.00
Lupin 2120.00
Zydus Lifesciences 1161.50
View more..